tiprankstipranks
Advertisement
Advertisement

LRMR Stock Latest News

Larimar Therapeutics initiated with an Overweight at JPMorgan
The FlyLarimar Therapeutics initiated with an Overweight at JPMorgan
1d ago
LRMR
Larimar Shareholders Approve Governance and Capital Structure Changes
PremiumCompany Announcements
Larimar Shareholders Approve Governance and Capital Structure Changes
9d ago
8K
LRMR
Larimar Therapeutics: Buy Rating Backed by Superior Nomlabofusp Data and Favorable Risk-Reward Versus Design Therapeutics
PremiumRatings
Larimar Therapeutics: Buy Rating Backed by Superior Nomlabofusp Data and Favorable Risk-Reward Versus Design Therapeutics
10d ago
LRMR
Larimar Therapeutics price target lowered to $12 from $13 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target lowered to $12 from $13 at Wedbush
10d ago
LRMR
Larimar Therapeutics price target lowered to $12 from $13 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target lowered to $12 from $13 at Wedbush
13d ago
LRMR
Larimar Therapeutics Reaffirmed as Buy on Nomlabofusp Progress and Regulatory De-Risking; $25 Price Target Maintained
PremiumRatingsLarimar Therapeutics Reaffirmed as Buy on Nomlabofusp Progress and Regulatory De-Risking; $25 Price Target Maintained
13d ago
LRMR
Myles Minter Reiterates Buy on Larimar as Nomlabofusp Advances Toward 2026 BLA and Potential First Disease‑Modifying FA Therapy by 2027
Premium
Ratings
Myles Minter Reiterates Buy on Larimar as Nomlabofusp Advances Toward 2026 BLA and Potential First Disease‑Modifying FA Therapy by 2027
14d ago
LRMR
Larimar Therapeutics reports Q1 EPS (31c), consensus (57c)
Premium
The Fly
Larimar Therapeutics reports Q1 EPS (31c), consensus (57c)
14d ago
LRMR
Larimar Details Q1 Results and Nomlabofusp Regulatory Progress
PremiumCompany Announcements
Larimar Details Q1 Results and Nomlabofusp Regulatory Progress
14d ago
8K
LRMR
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
23d ago
LRMR
Nomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR
PremiumRatings
Nomlabofusp’s Manageable Risk, Strong Efficacy Signals, and Significant FA Market Upside Underpin Buy Rating on LRMR
2M ago
LRMR
Larimar Therapeutics price target raised to $13 from $12 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target raised to $13 from $12 at Wedbush
2M ago
LRMR
Larimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
PremiumRatingsLarimar Therapeutics: Undervalued First-in-Class Frataxin Replacement with Favorable Regulatory Path and 2026 Inflection Point
2M ago
LRMR
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
Premium
The Fly
Larimar Therapeutics reports Q4 EPS (73c), consensus (55c)
2M ago
LRMR
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
LRMR
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
PremiumCompany Announcements
Larimar Advances Nomlabofusp Toward 2026 BLA Submission
3M ago
8K
LRMR
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
PremiumThe Fly
Larimar Therapeutics price target raised to $12 from $11 at Wedbush
3M ago
LRMR
Larimar Therapeutics Announces Upsized Public Equity Offering
PremiumCompany Announcements
Larimar Therapeutics Announces Upsized Public Equity Offering
3M ago
8K
LRMR
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
PremiumThe Fly
Larimar Therapeutics 20M share Spot Secondary priced at $5.00
3M ago
LRMR
Larimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
PremiumThe FlyLarimar Therapeutics $75M Spot Secondary price range $4.75-$5.25
3M ago
LRMR
Larimar Therapeutics price target raised to $14 from $12 at Citi
Premium
The Fly
Larimar Therapeutics price target raised to $14 from $12 at Citi
3M ago
LRMR
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
Premium
The Fly
Midday Fly By: Home Depot reports Q4 beat, AMD and Meta expand partnership
3M ago
HD
AMD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >